Cargando…
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948932/ https://www.ncbi.nlm.nih.gov/pubmed/33661860 http://dx.doi.org/10.15585/mmwr.mm7009e4 |
| _version_ | 1783663458514894848 |
|---|---|
| author | Oliver, Sara E. Gargano, Julia W. Scobie, Heather Wallace, Megan Hadler, Stephen C. Leung, Jessica Blain, Amy E. McClung, Nancy Campos-Outcalt, Doug Morgan, Rebecca L. Mbaeyi, Sarah MacNeil, Jessica Romero, José R. Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Dooling, Kathleen |
| author_facet | Oliver, Sara E. Gargano, Julia W. Scobie, Heather Wallace, Megan Hadler, Stephen C. Leung, Jessica Blain, Amy E. McClung, Nancy Campos-Outcalt, Doug Morgan, Rebecca L. Mbaeyi, Sarah MacNeil, Jessica Romero, José R. Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Dooling, Kathleen |
| author_sort | Oliver, Sara E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7948932 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79489322021-03-19 The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 Oliver, Sara E. Gargano, Julia W. Scobie, Heather Wallace, Megan Hadler, Stephen C. Leung, Jessica Blain, Amy E. McClung, Nancy Campos-Outcalt, Doug Morgan, Rebecca L. Mbaeyi, Sarah MacNeil, Jessica Romero, José R. Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Dooling, Kathleen MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-03-05 /pmc/articles/PMC7948932/ /pubmed/33661860 http://dx.doi.org/10.15585/mmwr.mm7009e4 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Oliver, Sara E. Gargano, Julia W. Scobie, Heather Wallace, Megan Hadler, Stephen C. Leung, Jessica Blain, Amy E. McClung, Nancy Campos-Outcalt, Doug Morgan, Rebecca L. Mbaeyi, Sarah MacNeil, Jessica Romero, José R. Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Dooling, Kathleen The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title_full | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title_fullStr | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title_full_unstemmed | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title_short | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 |
| title_sort | advisory committee on immunization practices’ interim recommendation for use of janssen covid-19 vaccine — united states, february 2021 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948932/ https://www.ncbi.nlm.nih.gov/pubmed/33661860 http://dx.doi.org/10.15585/mmwr.mm7009e4 |
| work_keys_str_mv | AT oliversarae theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT garganojuliaw theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT scobieheather theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT wallacemegan theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT hadlerstephenc theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT leungjessica theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT blainamye theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT mcclungnancy theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT camposoutcaltdoug theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT morganrebeccal theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT mbaeyisarah theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT macneiljessica theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT romerojoser theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT talbothkeipp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT leegracem theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT bellbethp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT doolingkathleen theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT oliversarae advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT garganojuliaw advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT scobieheather advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT wallacemegan advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT hadlerstephenc advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT leungjessica advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT blainamye advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT mcclungnancy advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT camposoutcaltdoug advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT morganrebeccal advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT mbaeyisarah advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT macneiljessica advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT romerojoser advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT talbothkeipp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT leegracem advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT bellbethp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 AT doolingkathleen advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofjanssencovid19vaccineunitedstatesfebruary2021 |